hotspot -WSS

hotspot

author：focus 2025-09-27 23:31:12 - browse：7

A sign of The Cigna Group in front of trees with orange and green leaves — insurance overage from STAT — Joe Buglewicz/Bloomberg

Cigna and Humana are in discussions to merge, a potential move that would create a health insurance and prescription drug benefits titan with approximately $300 billion of annual revenue.

A proposed transaction would almost certainly prompt a close review from antitrust enforcers at the Department of Justice and the Federal Trade Commission. A merged Cigna-Humana would further consolidate the market for pharmacy benefit managers. PBMs are companies that serve as the controversial middlemen of drug pricing negotiations, and of the four largest, two are owned by Cigna and Humana.

The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Kenai launches with $82 million for Parkinson’s stem cell therapy

WSS

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Virtual Event: March of the Biosimilars

Clinical trials giant ICON acquires HumanFirst

Flu vaccine offering decent levels of protection this winter, new data show

Physicians and social media: If you see something, say something?

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

leisure time

hotspot

focus

Bright Health sells Medicare Advantage business to Molina

International team creates first chimeric human

The high cost of giving birth even with insurance

U.K. researchers warn about biases in medical devices, algorithms

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

In search for therapies for solid tumors, companies turn to claudin

Apple is now the first public company to be valued at $3 trillion

Positive childhood experiences can help future health

How one medical school became remarkably diverse

Nurses recount patients attacks

leisure time

House looks to weaken Medicare negotiation

In search for therapies for solid tumors, companies turn to claudin

Asbestos, a deadly carcinogen, banned by EPA

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Change Healthcare cyberattack outage could last weeks

Stop the failed accountable care organization experiment

entertainment

hotspot

hotspot

explore